End-Stage Renal Disease
| Autor: | Emile Mohammed |
|---|---|
| Rok vydání: | 2008 |
| Předmět: |
Nephrology
medicine.medical_specialty education.field_of_study business.industry medicine.medical_treatment Population Urea reduction ratio Disease urologic and male genital diseases Intensive care unit Peritoneal dialysis law.invention End stage renal disease law Internal medicine medicine Renal replacement therapy education business Intensive care medicine |
| Zdroj: | Competency-Based Critical Care ISBN: 9781846289361 |
| DOI: | 10.1007/978-1-84628-937-8_12 |
| Popis: | There are now approximately one million people on renal replacement therapy worldwide. In the current era of chronic noncommunicable disease, this number is set to double within the next decade. Patients with end-stage renal disease (ESRD) carry a significantly higher cardiovascular morbidity and mortality compared with the general population. This is because of the “uremic” cardiovascular factors (Table 12.1). The result is that there will be a growing number of ESRD patients being managed within the intensive care unit (ICU) setting. Open image in new window Table 12.1 Cardiovascular risk factors in the uremic patient |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|